Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 1;7(8):5002-5006.
doi: 10.1039/c6sc01095d. Epub 2016 May 6.

Visible light amination/Smiles cascade: access to phthalazine derivatives

Affiliations

Visible light amination/Smiles cascade: access to phthalazine derivatives

Etienne Brachet et al. Chem Sci. .

Abstract

We report the synthesis of various phthalazines via a new cascade reaction, initiated by visible light photocatalysis, involving a radical hydroamination reaction followed by a radical Smiles rearrangement. Phthalazine derivatives are obtained in high yields and from a broad scope readily accessible ortho-alkynylsulfonohydrazone precursors. The mild photoredox conditions ensure an excellent functional group tolerance. Application of this strategy to a one-pot protocol starting from the corresponding carbonyl compounds, and subsequent functionalization allow the rapid synthesis of structurally diverse structures.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Phthalazines bioactive compounds.
Scheme 1
Scheme 1. State of art in radical hydro- and oxo-amination reactions and in the radical Smiles rearrangement (A and B); our photocatalyzed cascade (C).
Scheme 2
Scheme 2. Functionalization of halogenobenzhydrylphthalazines.
Scheme 3
Scheme 3. Proposed mechanism.

Similar articles

Cited by

References

    1. Heterocycles in Natural Product Synthesis, ed. K. C. Majumdar and S. K. Chattopadhyay, Wiley, Hoboken, NJ, 2012.
    2. Horton D. A., Bourne G. T., Smythe M. L. Chem. Rev. 2003;103:893. - PubMed
    3. Deiters A., Martin S. F. Chem. Rev. 2004;104:2199. - PubMed
    4. de Sá Alves F. R., Barreiro E. J., Fraga C. A. Mini-Rev. Med. Chem. 2009;9:782. - PubMed
    5. Brancale A., Silvestri R. Med. Res. Rev. 2007;27:209. - PubMed
    6. Zeni G., Larock R. Chem. Rev. 2004;104:2285. - PubMed
    1. Ibrahim H. S., Eldehna W. M., Abdel-Aziz H. A., Elaasser M. M., Abdel-Aziz M. M. Eur. J. Med. Chem. 2014;85:480. - PubMed
    1. Scott E. N., Meinhardt G., Jacques C., Laurent D., Thomas A. L. Expert Opin. Invest. Drugs. 2007;16:367. - PubMed
    1. Asif M. Curr. Med. Chem. 2012;19:2984. - PubMed
    2. Dong C., Liao Z., Xu X., Zhou H. J. Heterocycl. Chem. 2014;51:1282.
    3. Munína J., Santanab L., Uriarteb E., Borgesc F., Quezada E. Tetrahedron Lett. 2015;56:828.
    4. Maki Y., Furuta T., Suzuki M. J. Chem. Soc., Perkin Trans. 1. 1979:553.
    5. Heinisch G., Huber T. J. Heterocycl. Chem. 2009;26:1787.
    1. Suh S.-E., Barros S. A., Chenoweth D. M. Chem. Sci. 2015;6:5128–5132. - PMC - PubMed